An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU)

Data sources

• Data source(s):
  Danish registries (access/analysis)

  Système National des Données de Santé (French national health system main database)

  Sweden National Prescribed Drugs Register / Läkemedelsregistret

  Sweden National Cancer Register / Cancerregistret

  Swedish Cause of Death Register

  Landspatientregisteret (National Patient Register)
• Data source(s), other:
  Total Population Register

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No